These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20555263)

  • 1. Coronary stent length predicts PCI-induced cardiac myonecrosis.
    Hoole SP; Heck PM; Sharples L; Dutka DP; West NE
    Coron Artery Dis; 2010 Aug; 21(5):312-7. PubMed ID: 20555263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis.
    Hong YJ; Mintz GS; Kim SW; Lee SY; Okabe T; Pichard AD; Satler LF; Waksman R; Kent KM; Suddath WO; Weissman NJ
    JACC Cardiovasc Imaging; 2009 Apr; 2(4):458-68. PubMed ID: 19580729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention.
    Arora S; Alfayoumi F; Khawaja AT; Dua A; Srinivasan V; Gradman AH
    Clin Cardiol; 2009 Jun; 32(6):315-20. PubMed ID: 19569065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial injury following coronary artery surgery versus angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging.
    van Gaal WJ; Arnold JR; Testa L; Karamitsos T; Lim CC; Ponnuthurai FA; Petersen S; Francis JM; Selvanayagam J; Sayeed R; West N; Westaby S; Neubauer S; Banning AP
    EuroIntervention; 2011 Jan; 6(6):703-10. PubMed ID: 21205592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.
    Talarico GP; Brancati M; Burzotta F; Porto I; Trani C; De Vita M; Todaro D; Giammarinaro M; Leone AM; Niccoli G; Andreotti F; Mazzari MA; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):245-51. PubMed ID: 19262211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency, risk factors, and effect on long-term survival of increased troponin I following uncomplicated elective percutaneous coronary intervention.
    Loeb HS; Liu JC
    Clin Cardiol; 2010 Dec; 33(12):E40-4. PubMed ID: 21184543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up.
    Otto S; Seeber M; Fujita B; Kretzschmar D; Ferrari M; Goebel B; Figulla HR; Poerner TC
    Basic Res Cardiol; 2012 Sep; 107(5):289. PubMed ID: 22850870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary coronary microvascular dysfunction and poor coronary collaterals predict post-percutaneous coronary intervention cardiac necrosis.
    Hoole SP; White PA; Heck PM; Khan SN; Densem CG; Clarke SC; Shapiro LM; Schofield PM; O'Sullivan M; Dutka DP
    Coron Artery Dis; 2009 Jun; 20(4):253-9. PubMed ID: 19440064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
    Nageh T; Sherwood RA; Harris BM; Byrne JA; Thomas MR
    Int J Cardiol; 2003 Dec; 92(2-3):285-93. PubMed ID: 14659867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation.
    Lee T; Kakuta T; Yonetsu T; Takahashi K; Yamamoto G; Iesaka Y; Fujiwara H; Isobe M
    JACC Cardiovasc Interv; 2011 May; 4(5):483-91. PubMed ID: 21596319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.
    Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Lima EG; Vieira RD; Garcia RM; Favarato D; Segre CA; Pereira AC; Soares PR; Ribeiro E; Lemos P; Perin MA; Strunz CC; Dallan LA; Jatene FB; Stolf NA; Hueb AC; Dias R; Gaiotto FA; da Costa LM; Oikawa FT; de Melo RM; Serrano CV; de Ávila LF; Villa AV; Filho JR; Nomura C; Ramires JA; Kalil Filho R;
    BMC Cardiovasc Disord; 2012 Aug; 12():65. PubMed ID: 22898311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
    Zografos TA; Katritsis GD; Tsiafoutis I; Bourboulis N; Katsivas A; Katritsis DG
    Am J Cardiol; 2014 Jun; 113(12):2013-7. PubMed ID: 24793669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention.
    Gach O; Louis O; Chapelle JP; Vanbelle S; Pierard LA; Legrand V
    Heart Vessels; 2009 Jul; 24(4):267-70. PubMed ID: 19626398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.
    Fujii K; Kawasaki D; Oka K; Akahori H; Iwasaku T; Fukunaga M; Eguchi A; Sawada H; Masutani M; Lee-Kawabata M; Tsujino T; Ohyanagi M; Masuyama T
    JACC Cardiovasc Interv; 2011 May; 4(5):513-20. PubMed ID: 21596324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty.
    Tarantini G; Napodano M; Gasparetto N; Favaretto E; Marra MP; Cacciavillani L; Bilato C; Osto E; Cademartiri F; Musumeci G; Corbetti F; Razzolini R; Iliceto S
    Coron Artery Dis; 2010 Mar; 21(2):78-86. PubMed ID: 20071979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myonecrosis and inflammatory response following percutaneous coronary angioplasty. A protective role for betablockers?].
    Radulescu B; Morel O; Faure A; Jesel L; Roul G; Chauvin M; Ohlmann P; Bareiss P
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):27-33. PubMed ID: 18656848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach.
    Burzotta F; Trani C; Todaro D; Mariani L; Talarico GP; Tommasino A; Giammarinaro M; Niccoli G; Porto I; Leone AM; Mongiardo R; Mazzari MA; Schiavoni G; Crea F
    JACC Cardiovasc Interv; 2011 Mar; 4(3):327-35. PubMed ID: 21435612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P; Farooq V; Garg S; Van Es GA; Silber S; Windecker S; Stone GW; Serruys PW
    Heart; 2012 Oct; 98(19):1424-30. PubMed ID: 22821273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.